A drug that's been found to slow the progress of Alzheimer's disease by clearing proteins in the brain has been approved for ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

HSV-1 infection may be linked to the risk for Alzheimer’s disease, but antiviral treatment may be protective, a large ...

TREATING cold sores with anti-viral medicines could slash the risk of Alzheimer’s disease by 17 per cent, research suggests. Previous studies have found that the herpes simplex virus – ...

Alzheimer’s researcher Donald Weaver tells The Conversation Weekly podcast what he’s learnt during more than 30 years of ...

Dr Richard Oakley, director of research and innovation at the Alzheimer’s Society, said: “Results from this observational ...

Adoption of lecanemab, a novel infusion treatment for Alzheimer’s disease (AD), has been disproportionately higher among ...

The tangled nerve fibers Dr. Alzheimer found are now known to be a result ... s Health Research to improve prevention, diagnosis, and treatment of conditions that affect women disproportionately.

The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...

Lecanemab binds with high affinity to soluble amyloid-beta protofibrils. It won full FDA approval in July 2023 based on trial ...